ChiCTR2000038022 版本V1.3 版本创建时间2020/11/21 09:58:28 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000038022 

最近更新日期:

Date of Last Refreshed on:

2020-11-21 09:41:50 

注册时间:

Date of Registration:

2020-09-08 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

共聚焦激光显微内镜在微创保胆手术中的应用研究

Public title:

Application of Confocal Laser Microendoscopy In Choledochoscopic Gallbladder-preserving Surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

共聚焦激光显微内镜在微创保胆手术中的应用研究

Scientific title:

Application of Confocal Laser Microendoscopy In Choledochoscopic Gallbladder-preserving Surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

汤泊夫 

研究负责人:

党彤 

Applicant:

Bofu Tang 

Study leader:

Tong Dang 

申请注册联系人电话:

Applicant telephone:

+86 15044942608

研究负责人电话:

Study leader's
telephone:

+86 13948823999

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

tomloves@qq.com

研究负责人电子邮件:

Study leader's E-mail:

dtong999@sina.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

内蒙古自治区包头市青山区呼得木林大街30号

研究负责人通讯地址:

内蒙古自治区包头市青山区呼得木林大街30号

Applicant address:

30 Hudemulin Road, Qingshan District, Baotou, Innermongolia, China

Study leader's address:

30 Hudemulin Road, Qingshan District, Baotou, Innermongolia, China

申请注册联系人邮政编码:

Applicant postcode:

014030

研究负责人邮政编码:

Study leader's postcode:

014030

申请人所在单位:

内蒙古科技大学包头医学院第二附属医院

Applicant's institution:

The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology

研究负责人所在单位:

内蒙古科技大学包头医学院第二附属医院

Affiliation of the Leader:

The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2019年科伦审第(ZX-018))

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

包头医学院第二附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Second Affiliated Hospital of Baotou Medical College

伦理委员会批准日期:

Date of approved by ethic committee:

2020-01-13 00:00:00

伦理委员会联系人:

黄冠华

Contact Name of the ethic committee:

Huang Guanhua

伦理委员会联系地址:

内蒙古自治区包头市青山区呼得木林大街30号

Contact Address of the ethic committee:

30 Hudemulin Road, Qingshan District, Baotou, Innermongolia, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

内蒙古科技大学包头医学院第二附属医院

Primary sponsor:

The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology

研究实施负责(组长)单位地址:

内蒙古自治区包头市青山区呼得木林大街30号

Primary sponsor's address:

30 Hudemulin Road, Qingshan District, Baotou, Innermongolia, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

内蒙古自治区

市(区县):

包头

Country:

China

Province:

Innermongolia

City:

Baotou

单位(医院):

内蒙古科技大学包头医学院第二附属医院

具体地址:

青山区呼得木林大街30号

Institution
hospital:

The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology

Address:

30 Hudemulin Road, Qingshan District

经费或物资来源:

自筹

Source(s) of funding:

N/A

研究疾病:

胆囊疾病  

Target disease:

Gallbladder Disease

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

诊断试验新技术临床试验 

Study phase:

Diagnostic New Technique Clincal Study

研究设计:

病例研究 

Study design:

Case study 

研究目的:

1.利用探头式共聚焦激光显微内镜(probe-based confocal laser endomicroscopy, pCLE)从细胞层面快速、实时提供术中病理诊断的特性,针对胆囊结石、胆囊息肉患者联合腹腔镜、胆道镜在保胆手术中进行pCLE检查,术中对胆囊典型部位活检,对于术中pCLE观察到可疑肿瘤性病变或癌前病变的患者追加胆囊切除手术,pCLE诊断与病理诊断对照(pCLE与病理结果分别由同一经验丰富且具诊断资质医师给出),根据pCLE与病理诊断符合率,评价pCLE在保胆手术中术中病理诊断的应用价值; 2.根据不同部位(胆囊底、胆囊体、胆囊颈)、不同状态下(正常黏膜,炎症,腺瘤,恶性肿瘤等)pCLE胆囊黏膜特点,建立pCLE胆囊黏膜疾病诊断标准; 3.对术后患者结石复发或罹患胆囊肿瘤进行随访,评价pCLE在保胆手术中的应用价值,完善保胆手术指征。  

Objectives of Study:

1. Use the probe - -based confocal laser endomicroscopy(pCLE) quickly from cellular level, the features of real-time provide intraoperative pathological diagnosis, patients with gallstones, gallbladder polyp combined laparoscopic and choledochoscope pCLE inspections in biliary surgery, intraoperative biopsy for gallbladder typical parts, for intraoperative pCLE observed suspicious tumor patients with precancerous lesions or additional gallbladder surgery,The diagnostic value of pCLE in intraoperative pathological diagnosis is evaluated according to the coincidence rate between pCLE and pathological diagnosis. 2. According to the characteristics of gallbladder mucosa at different sites (fundus of gallbladder, body of gallbladder, neck of gallbladder) and under different conditions (normal mucosa, inflammation, adenoma, malignant tumor, etc.), diagnostic criteria for GALLbladder mucosal diseases of pCLE were established; 3. Patients with postoperative stone recurrence or gallbladder tumor were followed up to evaluate the application value of pCLE in biliary surgery and improve the indications of biliary surgery.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 胆囊结石患者;
2. 年龄18-70周岁;
3. 符合目前保胆取石术指征;
4. 同意行腹腔镜联合胆道镜保胆取石术;
5. 同意入组该研究并签署知情同意书。

Inclusion criteria

1. Patients with gallstone;
2. Patients aged 18-70 years;
3. The patients who meet the current indications of choledocholithotomy;
4. Patients who agreed to be treated by laparoscopy combined with choledochoscopy;
5. Patients who agreed to join the study and signed informed consent.

排除标准:

1. 有严重的心脑血管疾病,一般情况差,不能耐受手术,或有严重的精神障碍;
2. 有手术史或有其他合并症。

Exclusion criteria:

1. Patients with severe cardiovascular and cerebrovascular diseases are generally in poor condition, unable to tolerate surgery, or have serious mental disorders;
2. Patients with operation history or other complications.

研究实施时间:

Study execute time:

From 2020-09-07 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-09-07 00:00:00 To 2021-12-31 00:00:00

干预措施:

Interventions:

组别:

case series

样本量:

30

Group:

case series

Sample size:

干预措施:

干预措施代码:

Intervention:

Nil

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

内蒙古自治区 

市(区县):

包头 

Country:

China

Province:

Inner Mongolia

City:

Baotou

单位(医院):

包头医学院第二附属医院 

单位级别:

三级 

Institution
hospital:

The Second Affiliated Hospital of Baotou Medical College

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

细胞形态

指标类型:

主要指标

Outcome:

cellular morphology

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血管直径

指标类型:

主要指标

Outcome:

blood vessel diameter

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

一致性

指标类型:

主要指标

Outcome:

consistency

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

胆囊黏膜

组织:

胆囊

Sample Name:

the gallbladder mucosa

Tissue:

gallbladder

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

实验人员与手术医师、病理医师采用单盲法进行随机对照

Randomization Procedure (please state who generates the random number sequence and by what method):

The experimenter and the surgeon and pathologist are randomly controlled by single - blind method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

数据统计分析完成后,以文章发表的形式公开原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After the statistical analysis of the data is completed, the original data will be published in the form of articles.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-09-08 10:28:00